rs752143061

Variant summary

Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PS1_ModeratePM2PP3PP5_Very_Strong

The NM_024417.5(FDXR):​c.916C>T​(p.Arg306Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000411 in 1,607,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000041 ( 0 hom. )

Consequence

FDXR
NM_024417.5 missense

Scores

5
4
9

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 4.81
Variant links:
Genes affected
FDXR (HGNC:3642): (ferredoxin reductase) This gene encodes a mitochondrial flavoprotein that initiates electron transport for cytochromes P450 receiving electrons from NADPH. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 13 ACMG points.

PS1
Transcript NM_024417.5 (FDXR) is affected with MISSENSE_VARIANT having same AA change as one Pathogenic present in UniProt
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.764
PP5
Variant 17-74864234-G-A is Pathogenic according to our data. Variant chr17-74864234-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 441237.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-74864234-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FDXRNM_024417.5 linkuse as main transcriptc.916C>T p.Arg306Cys missense_variant 9/12 ENST00000293195.10 NP_077728.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FDXRENST00000293195.10 linkuse as main transcriptc.916C>T p.Arg306Cys missense_variant 9/121 NM_024417.5 ENSP00000293195 P3

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152176
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000289
AC:
7
AN:
241968
Hom.:
0
AF XY:
0.0000226
AC XY:
3
AN XY:
132768
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000874
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000372
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000405
AC:
59
AN:
1455194
Hom.:
0
Cov.:
34
AF XY:
0.0000346
AC XY:
25
AN XY:
722710
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000451
Gnomad4 OTH exome
AF:
0.0000500
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152294
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000565
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000165
AC:
2
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Auditory neuropathy-optic atrophy syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineDec 26, 2018The p.Arg337Cys variant in FDXR (also known as p.Arg306Cys) has been reported in 1 homozygous individual and 1 compound heterozygous individual with auditory n europathy and optic atrophy (Paul 2017). The variant segregated with disease in 3 relatives (Paul 2017). In vivo functional studies in yeast provide some eviden ce that the p.Arg337Cys variant may impact protein function (Paul 2017). However , these types of assays may not accurately represent biological function. This v ariant has been identified in 3/34332 Latino and 4/107544 European chromosomes b y the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). Co mputational prediction tools and conservation analysis do not provide strong sup port for or against an impact to the protein. In summary, although additional st udies are required to fully establish its clinical significance, the p.Arg337Cys variant is likely pathogenic. ACMG/AMP criteria applied: PP1_Strong, PM2, PM3, PS3_Supporting. -
Pathogenic, no assertion criteria providedliterature onlyOMIMOct 12, 2017- -
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsSep 06, 2022The c.934C>T (p.R312C) alteration is located in exon 9 (coding exon 9) of the FDXR gene. This alteration results from a C to T substitution at nucleotide position 934, causing the arginine (R) at amino acid position 312 to be replaced by a cysteine (C). Based on data from gnomAD, the T allele has an overall frequency of <0.01% (7/241968) total alleles studied. The highest observed frequency was 0.01% (3/34332) of Latino alleles. This alteration was detected in conjunction with another pathogenic FDXR mutation in an individual with bilateral auditory neuropathy, adolescent-onset hearing defects, and bilateral optic atrophy. In addition, this alteration was detected in the homozygous state and segregated with disease among multiple individuals in one family who had clinical features consistent with FDXR-related mitochondrial encephalomyopathy (Paul, 2017). This amino acid position is well conserved in available vertebrate species. Functional assays in patient fibroblasts show aberrant ferredoxin reductase levels, respiratory chain enzyme activity, and iron uptake (Paul, 2017). The in silico prediction for this alteration is inconclusive. Based on the available evidence, this alteration is classified as likely pathogenic. -
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxSep 01, 2023Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28965846, 33348459, 33938912) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Pathogenic
0.22
CADD
Pathogenic
33
DANN
Uncertain
1.0
DEOGEN2
Benign
0.16
.;.;.;.;T;.;T;T
Eigen
Benign
0.16
Eigen_PC
Benign
0.097
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Pathogenic
0.99
D;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.29
D
MetaRNN
Pathogenic
0.76
D;D;D;D;D;D;D;D
MetaSVM
Benign
-0.71
T
MutationTaster
Benign
1.0
D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-3.7
.;D;D;.;.;D;.;D
REVEL
Benign
0.21
Sift
Benign
0.044
.;D;D;.;.;D;.;T
Sift4G
Benign
0.083
T;T;T;T;T;T;T;T
Vest4
0.73
MutPred
0.58
Loss of MoRF binding (P = 0.0069);.;.;.;.;.;.;.;
MVP
0.96
MPC
0.41
ClinPred
0.61
D
GERP RS
3.6
gMVP
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs752143061; hg19: chr17-72860356; API